Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort

Ophthalmic Genetics

Volumn 29, Issue 1, 2008, Pages 11-15

  Uthra, Satagopan ^a   Raman, Rajiv ^b   Mukesh, Bickol N ^c   Rajkumar, Samuel A ^a   Padmaja, Kumari R ^b   Paul, Pradeep G ^b   Lakshmipathy, Praveena ^a   Gnanamoorthy, Perumal ^b   Sharma, Tarun ^b   McCarty, Catherine A ^c   Kumaramanickavel, Govindasamy ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b MEDICAL RESEARCH FOUNDATION   (India)

^c MARSHFIELD CLINIC   (United States)

Author keywords

Diabetic retinopathy; Genetic polymorphism; South India; Type 2 diabetes; VEGF

Indexed keywords

VASCULOTROPIN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS;

AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41149156947     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.1080/13816810701663527     Document Type: Article

References (22)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Ferrara HV, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1519-1520.
2. Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP. Insulin-Like Growth Factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol. 2004;165:457-469.
3. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998;101(6):1219-1224.
4. Chiarelli F, Santilli F, Mohn A. role of growth factors in the development of diabetic complications. Horm Res. 2000;53:53-67.
5. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthal. 2002;134:348-353.
6. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266:11947-11954.
7. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B and Pilger E. A Common 936 C/T Mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37:443-448.
8. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motorneurons against ischemic death. Nat. Genet. 2003;34:383-394.
9. Lambrechts D, Devriendt K, Driscoll DA, Goldmuntz E, Gewillig M, Vlietinck R, Collen D, Carmeliet P. Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study (Letter). J Med Genet. 2005;42:519-522.
10. Howell WM, Ali S, Rose-Zerilli MJ, Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet. 2005;42:485-490.
11. Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N and Comi GP. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol. 2005;57:373-380.
12. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, Patel AV, Thun MJ, Calle EE. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res. 2006;8(2):R22. Epub 2006 Apr 13.
13. Vannay A, Dunai G, Bányász I, Szabó M, Vámos R, Treszl A, Hajdú J, Tulassay T, Vásárhelyi B. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Paediatric Res. 2005; 57(3):396-398.
14. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. A common polymorphism in the 5-prime-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002; 51:1635-1639.
15. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis. 2006;12:336-341.
16. Rani PK, Raman R, Agarwal S, Paul PG, Uthra S, Margabandhu G, et al. Diabetic retinopathy screening model for rural population: Awareness and screening methodology. Rural Remote Health. 2005;5(4):350.
17. Agarwal S, Raman R, Paul PG, Rani PK, Uthra S, Gayathree R, et al. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): Study design and research methodology. Ophthalmic Epidemiol. 2005;12(2):143-153.
18. Klein R, Klein BEK, Magli YL, Brothers RJ, Meuer SM, Moss SE, et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986;93:1183-1187.
19. Flanagin A. Who wrote the Declaration of Helsinki? JAMA. 1997;277:926.
20. Wolff R, Gemmil R. Purifying and Analysing Genomic DNA. In: Bruce B, Green ED, Hieter P, Klaplholz S, Myeres RM, Riethman H, eds. Genome Analysis: A Laboratory Manual. Vol. 4. New York: Cold Spring Harbour Laboratory Press; 1998: 1-82.
21. Ray D, Mishra M, Ralph S, Read Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes. 2004;53:861-864.
22. Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, Inukai K, Inoue I, Kawasaki I, Mori K, Yoneya S, Katayama S. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun. 2005;333:679-685.